Kun Chen is a Senior Director at AstraZeneca, currently engaged in leading initiatives in drug development within the pharmaceutical and biotech industries. With over 23 years of experience, Kun previously held significant roles at Gilead Sciences and Bristol-Myers Squibb, specializing in biostatistics and oncology. Throughout their career, Kun has contributed to advancements in drug development and medical affairs, showcasing a robust background in statistics with a Ph.D. in the field from the University of Kentucky, where they are currently enrolled.
This person is not in the org chart
This person is not in any teams
This person is not in any offices